Women-Led Vaccine Network Hits 1,000 Members Worldwide
By Science Correspondent
Women scientists leading the fight against some of the world’s most dangerous diseases are celebrating a major milestone this International Women's Day.
Researchers from across the globe have joined forces through the vaccine research network VALIDATE Network, which has now grown to more than 1,000 members.
Among those marking the achievement is Professor Andrea Cooper from the University of Leicester, who has been part of the network since it first launched.
VALIDATE was founded in 2017 and has expanded rapidly from just 32 researchers to an international community spanning 79 countries.
The network brings together scientists, clinicians and global health experts working to develop vaccines for complex diseases including Tuberculosis, Leprosy, Leishmaniasis and Melioidosis.
Professor Cooper, who is also part of the university’s Tuberculosis Research Group, said reaching 1,000 members was an “incredible moment” for the project.
She said the network had grown into a powerful international community united by the shared goal of improving vaccine development and saving lives.
The milestone is particularly fitting on International Women’s Day, with the project led by a team of influential female scientists who are working to champion women in research.
While the network welcomes scientists of all backgrounds, its leadership team is focused on supporting women’s voices in science and encouraging the next generation of female researchers.
Since its creation, the network has sparked nearly 200 new research collaborations and produced more than 80 scientific publications.
Its conferences and events have attracted thousands of participants from around the world.
The initiative has also helped unlock more than £25 million in additional funding to support new research projects.
Professor Cooper said the network’s success is driven by collaboration, fresh ideas and a shared determination to tackle global health challenges.
She added that the programme continues to fund innovative projects and encouraged more researchers to join the growing global effort to develop life-saving vaccines.
